Antibody-Drug Conjugate SC16LD6.5

Known as: Anti-SC16 ADC SC16LD6.5, SC16LD6.5 
An antibody-drug conjugate (ADC) containing an antibody directed against the scr-like kinase Fyn3 (SC-16), conjugated to the cytotoxic agent D6.5… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2016
0120032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Notch ligand DLL3 has emerged as a novel therapeutic target expressed in small cell lung cancer (SCLC) and high-grade… (More)
Is this relevant?
2016
2016
Delta-like protein 3 (DLL3) is a novel and tractable tumor-initiating cell-associated target for the antibody-drug conjugate… (More)
Is this relevant?
2004
2004
In-situ studies of the kinetics of the nucleation and growth of the ’ phase, as well as of the phase strains in the single… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2003
2003
An in situ study of the kinetics of relaxation of the gamma-gamma' lattice mismatch in the single-crystal Ni-base superalloy SC16… (More)
Is this relevant?